Catalyst

Slingshot members are tracking this event:

Aduro Biotech (ADRO) expected to initiate Phase 1b/2 trial of ADU-214/JNJ-64041757 in lung cancer in 2017 (Partnership with Janssen)

Source Link:
https://seekingalpha.com/filing/3351398

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
ADRO Community voting in process
JNJ Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details Update on 11 Dec 2017: Status changed from planning to not yet recruiting.
http://adisinsight.s...
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Jun 07, 2018
Occurred Source:
http://investors.aduro.com/phoenix.zhtml?c=242043&p=irol-newsArticle&ID=2353774
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Adu-214, Lung Cancer, Phase 1b/2
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.